It is a modern pharmaceutical company with a history of nearly a hundred years, a state-owned holding company, and affiliated to Chongqing Chemical Medicine Holding (Group) Company. The products are sold in more than 30 provinces (municipalities, autonomous regions) across the country, as well as in India, Switzerland, South Korea, the United States, Japan, Europe and other countries and regions. He is hailed as "general medicine expert" and "essential medicine expert" by the industry.
Chongqing Kerui Pharmaceutical (Group) Co., Ltd. was founded in 1914 and was invested and founded by Mr. Song Ziwen in Hong Kong. It is a state-owned holding enterprise and affiliated to Chongqing Chemical Medicine Holding (Group) Company. The headquarters is now located in Chongqing Nan'an Economic and Technological Development Zone, covering an area of ??nearly 100 acres. The company has successively changed its name to Chongqing Pharmaceutical Factory, Chongqing Pharmaceutical No. 7 Factory, and Chongqing Kerui Pharmaceutical Co., Ltd., and on August 1, 2011, it was officially renamed Chongqing Kerui Pharmaceutical (Group) Co., Ltd.
Over the years, the company has been adhering to the purpose of running an enterprise with integrity, winning, and serving the society, and has continued to pioneer and innovate. So far, it has developed into a large-scale pharmaceutical industry group with two complete industrial chains of traditional Chinese medicine and chemical medicine, integrating medicinal material planting, Chinese and Western medicine research and development, pharmaceutical and health care product production, medical device production, and commercial trade. It has been among the top 100 pharmaceutical companies in China for many years. Strong ranks.
It has successively won the titles of "National High-tech Enterprise", "China's Excellent Integrity Enterprise", "Chongqing Time-honored Brand", "Quality and Efficiency Enterprise", "Municipal Civilized Unit", "Chongqing's Top Ten Industries Concerning People's Livelihood" Enterprise", "Responsible pharmaceutical company in the hearts of citizens" and other honorary titles. In 2011, the group's "See Picture Above" trademark was officially recognized as a well-known trademark in China by the State Administration for Industry and Commerce.
The group has two provincial-level engineering technology centers, hundreds of professional and technical personnel of various types, and more than 20 PhDs. In recent years, more than 10 new drugs of the Group have won the title of national and Chongqing key new products; more than 10 new drugs have been rated as high-tech products of Chongqing; 4 projects have been included in the Chongqing Technology Innovation Project of the Municipal Economic Commission; 2 projects have been awarded the title of Science and Technology Supported by the Ministry of National Major Special Funds, it has applied for nearly 100 patents and nearly 200 trademarks of various types. It has also launched a series of new products with high technological content, including 4 national Class I new drug certificates and dozens of Class II to V new drug certificates.
We have established QMS (Total Quality Management System) and EHS (Environmental Health and Safety Management System) to strictly control the pharmaceutical production management process, audit raw material suppliers, pharmaceutical production, quality control, product release, and after-sales All aspects including services are fully monitored to ensure the safety and reliability of product quality. Many products have passed European and American GMP certification.
The company produces more than 300 varieties, and more than 100 products have entered the "National Essential Medicine Catalog". It is praised by the industry as "General Medicine Expert" and "Essential Medicine Expert". It has many national exclusive varieties such as Danweidin, Compound Xiongdan Tong Nasal Spray, Guixiong Pollen Oral Liquid, Shensuo Morinda Oral Liquid, Dijianan, etc.; Desmodium Herba Granules, Medithromycin Tablets, Artemisinin, Protein More than 10 products, including valeric acid series drugs, Guixiang Qushu Powder, and meprobamate API, have ranked first in the country in market share for many years in a row due to their excellent product quality. The marketing network radiates across the country and is oriented internationally. The products are distributed throughout the country and exported to India, Switzerland, South Korea, the United States, Japan, Europe and other countries and regions.
According to the basic guiding ideology of the country’s “12th Five-Year Plan” for the development of the biopharmaceutical industry, the company has adopted the strategy of large-scale basic drugs, industrialization of new products, internationalization of industrial upgrading, industrial and commercial integration, and upstream and downstream extension of the industrial chain. Implementation, we are always committed to building a multi-field development of Kerui Health Industry Cluster, driving benefits with scale and cost advantages, and giving back to consumers with higher quality and better services.
“Taking care of the world and helping people with medicine” has been Kerui’s unchanged value pursuit for hundreds of years. In recent years, the company has donated money and materials worth more than 10 million yuan to various public welfare undertakings such as the southern snowstorm, the Wenchuan earthquake, the Wulong mountain collapse, the Dianjiang typhoon, the Yushu earthquake, the Red Cross, Chongqing sports, and greening the Yangtze River. The company has established standardized GAP Chinese medicinal material planting bases in many places, which has driven local medicinal farmers to become rich. We organize various activities of "delivering medicines to the countryside" and "delivering health under the new rural cooperative medical system" all year round to enhance consumers' understanding of healthy medicines and establish a good social reputation.